Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study of Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke

NCT03296618 is registered in ClinicalTrials.gov with Suzhou Neuralstem Biopharmaceuticals as lead sponsor.

NCT NCT03296618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03296618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study of Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke
Lead sponsor
Suzhou Neuralstem Biopharmaceuticals
Phase
Phase 1
Overall status
Unknown status
Start date
June 30, 2012
Completion date
May 31, 2018
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic motor stroke, chronic